Evidence map›Paper›PMID 20819874›Full record

ArticleBMJ (Clinical research ed.)2010

Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study.

Christopher Vinnard, Carla A Winston, E Paul Wileyto, Rob Roy Macgregor, Gregory P Bisson

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2019
    Guideline
  3. Isoniazid-resistant tuberculosis in children: a systematic review.The Pediatric infectious disease journal · 2013
    Pooled it
  4. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Tuberculosis Meningitis.Current infectious disease reports · 2017
    Review
  13. Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  14. Isoniazid-resistant tuberculosis: a cause for concern?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2017
    Review
  15. Traditional and syndromic surveillance of infectious diseases and pathogens.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2016
    Review
  16. Article
  17. Article
  18. Prognostic factors of tuberculous meningitis: a single-center study.International journal of clinical and experimental medicine · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christopher VinnardDepartment of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, 502 Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA. christopher.vinnard@uphs.upenn.edu
Carla A Winston
E Paul Wileyto
Rob Roy Macgregor
Gregory P Bisson
University of Pennsylvania · USCenters for Disease Control and Prevention · US

Funding

Infectious Diseases Epidemiology Training GrantT32AI055435 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2003 to 2023
$6.9M
NIAID NIH HHS T32 AI055435
6 · The paper itself

Abstract

objectiveTo determine whether initial isoniazid resistance is associated with death during the treatment of tuberculous meningitis.

designRetrospective cohort study.

settingNational Tuberculosis Surveillance System at the Centers for Disease Control in the United States.

participantsPatients with a clinical diagnosis of tuberculous meningitis, reported to the National Tuberculosis Surveillance System between 1 January 1993 and 31 December 2005.

main outcome measureAll cause mortality during antituberculous treatment.

resultsBetween 1993 and 2005, 1896 patients had a clinical diagnosis of tuberculous meningitis and positive cultures from any site. In 123 (6%) of these patients, isoniazid resistance was present on initial susceptibility testing. The unadjusted association between initial isoniazid resistance and subsequent death among these 1896 patients did not reach statistical significance (odds ratio 1.38, 95% confidence interval 0.94 to 2.02). However, among 1614 patients with positive cerebrospinal fluid cultures, a significant unadjusted association was found between initial isoniazid resistance and subsequent death (odds ratio 1.61, 1.08 to 2.40). This association increased after adjustment for age, race, sex, and HIV status (odds ratio 2.07, 1.30 to 3.29).

conclusionsIsoniazid resistance on initial susceptibility testing was associated with subsequent death among cases of tuberculous meningitis with positive cerebrospinal fluid cultures. Randomised controlled trials are needed to evaluate the optimal empirical regimen for treating patients with tuberculous meningitis who are at high risk for both initial isoniazid resistance and poor clinical outcomes.

Indexed as

AdolescentAdultAgedAntitubercular AgentsChildChild, PreschoolFemaleHumansInfantIsoniazidMaleMiddle AgedRegression AnalysisRetrospective StudiesTreatment OutcomeTuberculosis, MeningealAntitubercular AgentsIsoniazid

Identifiers

PMID20819874
PMCPMC2938884
OpenAlexW2018615176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.